Fledgling Neuroscience Society Provides Sharper Focus

A scientific society's burgeoning growth is usually seen as unadulterated good news for its members, promising, among other things, increased political clout for their discipline. But according to some scientists, very large societies can also have a downside. Size-related problems may include a disproportionate skewing of a society's focus away from small but important subdisciplines, and meetings whose overloaded formats make it hard for attendees to focus on science, researchers say. Some a

Written byMarcia Clemmitt
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Size-related problems may include a disproportionate skewing of a society's focus away from small but important subdisciplines, and meetings whose overloaded formats make it hard for attendees to focus on science, researchers say. Some argue that size-related problems can become so troubling that in themselves they form a spur for scientists to break away to form new, more focused societies.

A case in point may be the San Antonio, Texas-based International Behavioral Neuroscience Society (IBNS), established last May largely because of its members' dissatisfaction with the rapidly growing Society for Neuroscience as a forum for sharing their work.

"People were not happy with the large size of the [annual] Society for Neuroscience meeting and all the simultaneous presentations," says Matthew Wayner, Blumberg Professor of Life Sciences at the University of Texas, San Antonio, and first president of IBNS.

Wayner and others say they hope the fledgling society will help focus ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies